US 10239954
Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer
granted A61KA61K49/0032A61K49/0058
Quick answer
US patent 10239954 (Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer) held by The Regents of the University of California expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K49/0032, A61K49/0058, A61K51/1075